Denis P. Larsimont

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

Spatial and single-nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers.

Spatial and single-nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers.

Journal: Molecular oncology

Published: February 20, 2026

Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.

Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 04, 2026

Diagnostic accuracy of intraoperative macroscopic margin evaluation in breast-conserving surgery.

Diagnostic accuracy of intraoperative macroscopic margin evaluation in breast-conserving surgery.

Journal: Breast (Edinburgh, Scotland)

Published: January 11, 2026

Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

Journal: Nature medicine

Published: July 18, 2025

The role of body mass index at diagnosis in patients with inflammatory breast cancer.

The role of body mass index at diagnosis in patients with inflammatory breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: June 18, 2025

Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic accuracy trial of quantitative dose-timing assessment.

Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic accuracy trial of quantitative dose-timing assessment.

Journal: Trials

Published: January 26, 2025

Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Journal: Nature communications

Published: January 24, 2025

Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma.

Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 11, 2024

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

Journal: Breast cancer research : BCR

Published: November 22, 2024

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.

Journal: NPJ breast cancer

Published: November 01, 2024

Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.

Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.

Journal: Nature communications

Published: April 15, 2024

Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 02, 2024

Showing 1-12 of 135

Last Updated: 09/26/2026